Company News
High Force Research makes boardroom changes following retirement of Managing Director
High Force Research makes boardroom changes following retirement of Managing Director
Bob Redfern co-founded the firm in 1988
PlaqueTec appoints Dr Tim Brears as CEO
PlaqueTec appoints Dr Tim Brears as CEO
Cambridge firm is pioneering a biomarker-based approach to understanding coronary artery disease
EMD Serono appoints Scott Filosi as Senior Vice President of Managed Markets
EMD Serono appoints Scott Filosi as Senior Vice President of Managed Markets
Filosi brings 20 years of market access experience to the EMD Serono leadership team
David Kaysen named President and CEO of Sun BioPharma
David Kaysen named President and CEO of Sun BioPharma
He brings more than 25 years of healthcare, commercial and public company experience to the firm
Nuevolution welcomes two new faces
Nuevolution welcomes two new faces
Jeanette Wood joins the board as scientific advisor, while Henrik Simonsen joins the firm as Chief Financial Officer
Merck reorganises Healthcare management team
Merck reorganises Healthcare management team
Forms a new Healthcare Executive Committee to accelerate delivery of pipeline in immuno-oncology, immunology and oncology
Ian Tomlinson becomes Independent Chairman of Stevenage Bioscience Catalyst Board
Ian Tomlinson becomes Independent Chairman of Stevenage Bioscience Catalyst Board
Will guide open innovation campus in a phase of rapid development
InMed appoints Paul Brennan as President and CEO
InMed appoints Paul Brennan as President and CEO
He succeeds Craig Schneider who remains on the board of directors
New Chief Medical Officer at Endo
New Chief Medical Officer at Endo
Craig Paterson takes responsibility for global clinical development strategies at the company
Extract Technology appoints two engineering apprentices
Extract Technology appoints two engineering apprentices
Company is committed to the apprenticeship model as a way of introducing young adults into engineering
Michael Meyers joins Syndax Pharmaceuticals as SVP and Chief Development Officer
Michael Meyers joins Syndax Pharmaceuticals as SVP and Chief Development Officer
Brings significant experience in oncology drug development to expanding clinical programme
Vanda Pharmaceuticals hires European General Manager
Vanda Pharmaceuticals hires European General Manager
Gian Piero Reverberi has more than 20 years of pharma industry experience
I Holland appoints new Sales and Marketing Director
I Holland appoints new Sales and Marketing Director
Javier Raposo takes responsibility for business development
Dr John Hutchison joins Autifony Therapeutics as Chief Medical Officer
Dr John Hutchison joins Autifony Therapeutics as Chief Medical Officer
Dr Peter Harris will retire at the end of September
Kloeckner Pentaplast appoints Wayne M Hewett as CEO
Kloeckner Pentaplast appoints Wayne M Hewett as CEO
He joins the firm from Arysta LifeScience
AmpliPhi Biosciences appoints Alexander Gaidamaka as Vice President of CMC
AmpliPhi Biosciences appoints Alexander Gaidamaka as Vice President of CMC
Will oversee the compliant manufacture and quality assurance of phage-based therapeutics
Basilea's Chief Technology Officer to retire
Basilea's Chief Technology Officer to retire
Dr Günter Ditzinger named as successor Dr Ingrid Heinze-Krauss
Organisational changes at AMRI
Organisational changes at AMRI
Changes are expected to drive growth for the Discovery and Development Solutions (DDS) business and ensure it is well aligned with the needs of the market
Pivotal expands international business with new VP of Central and Northern Europe
Pivotal expands international business with new VP of Central and Northern Europe
Will focus on expanding Pivotal's international presence in Central and Northern Europe, with special emphasis on Germany and Scandinavia
Halo Pharmaceutical names new CEO
Halo Pharmaceutical names new CEO
CDMO makes two key additions to management team
Michael Labarre becomes Chief Scientific Officer at Halozyme Therapeutics
Michael Labarre becomes Chief Scientific Officer at Halozyme Therapeutics
His career in biotech drug discovery and development spans two decades
M Pharmaceutical hires new Chief Executive
M Pharmaceutical hires new Chief Executive
Matthew Lehman joins the company as Martin Mintchev moves to Chief Scientific Officer
AstraZeneca appoints EVP of Global Medicines Development and Chief Medical Officer
AstraZeneca appoints EVP of Global Medicines Development and Chief Medical Officer
Dr Sean Bohen joins the company on 15 September
AdvantaPure welcomes Mark Mistretta as US East Coast Sales Manager
AdvantaPure welcomes Mark Mistretta as US East Coast Sales Manager
Brings more than 20 years of sales and engineering experience to the single-use tubing company